Key financial metrics and fundamentals for Keros Therapeutics, Inc. (KROS).
Market Cap
$358.8M
P/E Ratio
-4.90
Forward P/E
--
EPS
$-2.29
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High